These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 35099996)

  • 1. In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleeding.
    Chaudhuri D; Rochwerg B
    Ann Intern Med; 2022 Feb; 175(2):JC18. PubMed ID: 35099996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal dosing of heparin for prophylactic anticoagulation in critically ill COVID-19 patients a systematic review and meta-analysis of randomized controlled trials.
    Bonfim LCMG; Guerini IS; Zambon MG; Pires GB; Silva ACF; Gobatto ALN; Lopes MA; Brosnahan SB
    J Crit Care; 2023 Oct; 77():154344. PubMed ID: 37244209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials.
    Ortega-Paz L; Galli M; Capodanno D; Franchi F; Rollini F; Bikdeli B; Mehran R; Montalescot G; Gibson CM; Lopes RD; Andreotti F; Angiolillo DJ
    Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(7):677-686. PubMed ID: 34519777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant Treatment Regimens in Patients With Covid-19: A Meta-Analysis.
    Jorda A; Siller-Matula JM; Zeitlinger M; Jilma B; Gelbenegger G
    Clin Pharmacol Ther; 2022 Mar; 111(3):614-623. PubMed ID: 34862791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of prophylactic anticoagulation versus therapeutic anticoagulation in hospital-admitted COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials.
    Rauniyar R; Kuikel S; Mishra A; Rauniyar R; Yadav S; Thapaliya S; Nepal AS; Rauniyar R
    Clin Respir J; 2023 Feb; 17(2):73-79. PubMed ID: 36572657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated meta-analysis of randomized controlled trials on the safety and efficacy of different prophylactic anticoagulation dosing regimens in non-critically ill hospitalized patients with COVID-19.
    Ortega-Paz L; Galli M; Angiolillo DJ
    Eur Heart J Cardiovasc Pharmacother; 2022 May; 8(3):E15-E17. PubMed ID: 35108396
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
    ; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
    JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials.
    Kow CS; Ramachandram DS; Hasan SS
    J Infect Chemother; 2022 Feb; 28(2):257-265. PubMed ID: 34840039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.
    Moonla C; Sosothikul D; Chiasakul T; Rojnuckarin P; Uaprasert N
    Clin Appl Thromb Hemost; 2021; 27():10760296211008999. PubMed ID: 33874753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In COVID-19, therapeutic vs. prophylactic anticoagulation did not improve clinical outcomes and increased bleeding.
    Diep R; Garcia D
    Ann Intern Med; 2021 Oct; 174(10):JC112. PubMed ID: 34606319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation and bleeding risk in patients with COVID-19.
    Musoke N; Lo KB; Albano J; Peterson E; Bhargav R; Gul F; DeJoy R; Salacup G; Pelayo J; Tipparaju P; Azmaiparashvili Z; Patarroyo-Aponte G; Rangaswami J
    Thromb Res; 2020 Dec; 196():227-230. PubMed ID: 32916565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In critically ill patients with COVID-19, therapeutic anticoagulation did not increase organ support-free days.
    Donato AA
    Ann Intern Med; 2021 Dec; 174(12):JC135. PubMed ID: 34871054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous Thromboembolism in Hospitalized COVID-19 Patients.
    Sridharan GK; Vegunta R; Rokkam VRP; Meyyur Aravamudan V; Vegunta R; Khan SR; Ponnada S; Boregowda U; Prudhvi K; Chamarthi G; Mohan BP
    Am J Ther; 2020; 27(6):e599-e610. PubMed ID: 33156016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia.
    Tacquard C; Mansour A; Godon A; Godet J; Poissy J; Garrigue D; Kipnis E; Rym Hamada S; Mertes PM; Steib A; Ulliel-Roche M; Bouhemad B; Nguyen M; Reizine F; Gouin-Thibault I; Besse MC; Collercandy N; Mankikian S; Levy JH; Gruel Y; Albaladejo P; Susen S; Godier A;
    Chest; 2021 Jun; 159(6):2417-2427. PubMed ID: 33465342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [COVID-19, anticoagulation and venous thromboembolism: what have we learned ?].
    Blondon M; Robert-Ebadi H
    Rev Med Suisse; 2021 Dec; 17(762):2140-2144. PubMed ID: 34878743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
    Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
    Thromb Res; 2020 Dec; 196():313-317. PubMed ID: 32977129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In noncritical COVID-19, therapeutic vs. prophylactic anticoagulation did not reduce a composite adverse clinical outcome at 30 d.
    DeLoughery TG
    Ann Intern Med; 2023 Aug; 176(8):JC93. PubMed ID: 37523703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The single-dose J&J vaccine had 67% efficacy against moderate to severe-critical COVID-19 at ≥14 d.
    Sacks HS
    Ann Intern Med; 2021 Jul; 174(7):JC75. PubMed ID: 34224270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracranial hemorrhage complicating anticoagulant prophylactic therapy in three hospitalized COVID-19 patients.
    Ghani MU; Kumar M; Ghani U; Sonia F; Abbas SA
    J Neurovirol; 2020 Aug; 26(4):602-604. PubMed ID: 32572835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.